NCT04911023 (ANOFIS) is a clinical trial in Fissure Rectal, sponsored by Fondation Hôpital Saint-Joseph.

Who is sponsoring NCT04911023?

NCT04911023 is sponsored by Fondation Hôpital Saint-Joseph.

What condition does NCT04911023 study?

NCT04911023 studies Fissure Rectal.

Is NCT04911023 still recruiting?

NCT04911023 is currently completed. Last updated 28 April 2023.

Last reviewed 2023-04-28 · How we verify

NCT04911023: ANOFIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Fissurectomy to Fissurectomy With Anoplasty

Completed Last updated 28 April 2023

What this trial tests

trial in Fissure Rectal in 226 participants. Completed in 5 October 2022.

Timeline

6 May 2021

Primary endpoint
6 August 2021

5 October 2022

Quick facts

Lead sponsor	Fondation Hôpital Saint-Joseph
Status	Completed
Study type	OBSERVATIONAL
Enrollment	226
Start date	6 May 2021
Primary completion	6 August 2021
Estimated completion	5 October 2022
Sites	1 location across France

Conditions studied

Fissure Rectal — all drugs for Fissure Rectal →

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

18 and older, any sex, with Fissure Rectal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Surgery is sometimes necessary to relieve patients with chronic anal fissure. It consists of resecting the edges of the fissure to make a wound larger than the initial fissure, in order to obtain healing. Thus, the edges of the wound do not stick together and the healing is done from the bottom of the wound. This procedure is widely performed in France with results that seem satisfactory. In addition to resection of the fissure, a partial closure of the wound can be associated with a small flap of rectal mucosa which is sutured with a few absorbable stitches: this is anoplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Fondation Hôpital Saint-Joseph trials

Trials by the same sponsor.

NCT07512960 — Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization · Phase 3 · not yet recruiting
NCT07512908 — Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Di · NA · not yet recruiting
NCT07512830 — Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography · NA · recruiting
NCT07348081 — Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers · NA · recruiting
NCT07086612 — Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Transverse Orthodontic Deficiency in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04911023 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondation Hôpital Saint-Joseph
Last refreshed: 28 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04911023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing